Search

Your search keyword '"Dufour J.-F."' showing total 356 results

Search Constraints

Start Over You searched for: Author "Dufour J.-F." Remove constraint Author: "Dufour J.-F."
356 results on '"Dufour J.-F."'

Search Results

1. A global research priority agenda to advance public health responses to fatty liver disease

2. Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆” [J Hepatol (2020) 505–515, (S0168827820302130), (10.1016/j.jhep.2020.04.003)]

5. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD : an individual patient data meta-analysis

7. Screening for Hepatocellular Carcinoma among adults with HIV/Hepatitis B coinfection in Zambia: A Pilot Study

8. Global multi-stakeholder endorsement of the MAFLD definition

9. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

15. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis

16. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

17. Corrigendum to: 'Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort'☆ (J Hepatol [2020] 505–515) (Journal of Hepatology (2020) 73(3) (505–515), (S0168827820302130), (10.1016/j.jhep.2020.04.003))

18. Corrigendum to: “Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort”☆ (J Hepatol [2020] 505–515) (Journal of Hepatology (2020) 73(3) (505–515), (S0168827820302130), (10.1016/j.jhep.2020.04.003))

22. COVID-19 in an international European liver transplant recipient cohort

23. The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

24. The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

25. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

26. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret

27. Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat

29. Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naïve patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial

36. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies

38. Trends in hepatitis C-related mortality in Switzerland

43. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

44. Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis

45. High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1–6 patients without cirrhosis

46. Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis

Catalog

Books, media, physical & digital resources